Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Inoue

Showing results (821-830 of 847) with videos related to

Pageof 85
Sort By:
Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants - Insights From the COMMAND VTE Registry-2Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Immunity|September 11, 2021
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable siteTaishi Onodera, Shunsuke Kita, Yu Adachi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2024
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism - Insights From the COMMAND VTE Registry-2Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, et al.
Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of the American Heart Association|July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant EraKazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 27, 2018
Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE RegistryYugo Yamashita, Takeshi Morimoto, Hidewo Amano, et al.
JACC. Cardiooncology|June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral AnticoagulantsTomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.
Thrombosis and Haemostasis|April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Pageof 85

Showing results (821-830 of 847) with videos related to

Sort By:
Pageof 85
Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants - Insights From the COMMAND VTE Registry-2Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Immunity|September 11, 2021
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable siteTaishi Onodera, Shunsuke Kita, Yu Adachi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2024
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism - Insights From the COMMAND VTE Registry-2Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, et al.
Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of the American Heart Association|July 31, 2024
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant EraKazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 27, 2018
Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE RegistryYugo Yamashita, Takeshi Morimoto, Hidewo Amano, et al.
JACC. Cardiooncology|June 17, 2026
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral AnticoagulantsTomoyuki Nagai, Naohiko Nakanishi, Yugo Yamashita, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 26, 2025
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, et al.
Thrombosis and Haemostasis|April 29, 2024
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Pageof 85